Author:
Peeva Elena,Banerjee Anindita,Banfield Christopher,Soma Koshika,Christensen Jared,Menon Sandeep,Vincent Michael S.,Dolsten Mikael
Reference23 articles.
1. Efficient two-stage sequential arrays of proof of concept studies for pharmaceutical portfolios;He;Stat Methods Med Res,2021
2. Reviving an R&D pipeline: a step change in the phase II success rate;Wu;Drug Discov Today,2021
3. Achieving end-to-end success in the clinic: Pfizer's learnings on R&D productivity;Fernando;Drug Discov Today,2022
4. The safety, tolerability, pharmacokinetics, and pharmacodynamics of a TYK2/JAK1 inhibitor (PF-06700841) in healthy subjects and patients with plaque psoriasis;Banfield;J Clin Pharmacol,2018
5. First-in-human, randomized dose-escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity of PF-06480605 in healthy subjects;Banfield;Br J Clin Pharmacol,2020